These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23367501)

  • 21. Economic grand rounds: economic costs of failure to monitor adverse effects of second-generation antipsychotics: an underestimated factor.
    Jerrell JM; McIntyre RS; Black GB
    Psychiatr Serv; 2012 Mar; 63(3):202-4. PubMed ID: 22388526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.
    De Hert M; Detraux J; van Winkel R; Yu W; Correll CU
    Nat Rev Endocrinol; 2011 Oct; 8(2):114-26. PubMed ID: 22009159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limiting access to psychiatric services can increase total health care costs.
    Horn SD
    J Clin Psychiatry; 2003; 64 Suppl 17():23-8. PubMed ID: 14680424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An analysis of the effects of organization and financing on the utilization and costs of public mental health services in san diego county.
    Gilmer T
    J Ment Health Policy Econ; 2007 Sep; 10(3):123-32. PubMed ID: 17890829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antipsychotic medication on psychiatric service utilization and cost.
    Rothbard A; Murrin MR; Jordan N; Kuno E; McFarland BH; Stroup TS; Morrissey JP; Stiles PG; Boothroyd RA; Merwin E; Shern DL
    J Ment Health Policy Econ; 2005 Jun; 8(2):83-93. PubMed ID: 15998980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic drugs & their side effects.
    Jaco R
    Indian J Med Res; 2009 Feb; 129(2):208-9; author reply 209. PubMed ID: 19293453
    [No Abstract]   [Full Text] [Related]  

  • 28. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events in children and adolescents treated with antipsychotic medications.
    Jerrell JM; McIntyre RS
    Hum Psychopharmacol; 2008 Jun; 23(4):283-90. PubMed ID: 18302312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome: epidemiology and consequences.
    Sacks FM
    J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
    Newcomer JW
    J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mental health provider perspectives regarding integrated medical care for patients with serious mental illness.
    Kilbourne AM; Greenwald DE; Bauer MS; Charns MP; Yano EM
    Adm Policy Ment Health; 2012 Nov; 39(6):448-57. PubMed ID: 21735302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating the psychopharmacology of antipsychotics to individualized treatment for severe mental illness: a Roadmap.
    Weiden PJ; Preskorn SH; Fahnestock PA; Carpenter D; Ross R; Docherty JP;
    J Clin Psychiatry; 2007; 68 Suppl 7():1-48. PubMed ID: 17650057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical use of long-acting medications in the treatment of severe and persistent mental illnesses.
    Roberts LW; Geppert CM
    Compr Psychiatry; 2004; 45(3):161-7. PubMed ID: 15124145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia.
    Vancampfort D; Knapen J; Probst M; van Winkel R; Deckx S; Maurissen K; Peuskens J; De Hert M
    Psychiatry Res; 2010 May; 177(3):271-9. PubMed ID: 20406713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Time for every psychiatric clinic to take full responsibility for metabolic side effects of antipsychotic drugs!].
    Gothefors D; Jarbin H
    Lakartidningen; 2010 Mar 24-30; 107(12):845-6. PubMed ID: 20432835
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention and treatment of somatic complications arising from the use of antipsychotics].
    Cahn W; Ramlal D; Bruggeman R; de Haan L; Scheepers FE; van Soest MM; Assies J; Slooff CJ
    Tijdschr Psychiatr; 2008; 50(9):579-91. PubMed ID: 18785105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenges of clinical psychopharmacological management.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 May; 50(5):17-20. PubMed ID: 22533844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.